# Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

> **NCT04100824** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 40 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **PROCEDURE:** stellate ganglion block by transcranial doppler
- **DRUG:** Nimodipine

## Key facts

- **NCT ID:** NCT04100824
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-11
- **Primary completion:** 2022-12-11
- **Final completion:** 2023-01-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100824, "Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04100824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*